Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

cilastatin

- PMLiVE

Pharma clinical data sharing policy comes into effect

GSK and Sanofi among companies to announce public support of new guidelines

EU flag

MEPs agree clinical trial regulation revision

Paves way for EU trial database and simplified online applications for new studies

- PMLiVE

BIA: Political compromises could undermine EU trial reform

UK biotech body speaks out on eve of crucial committee hearing

Merck turns to gamification in diabetes

Working with Ayogo on mobile app to improve adherence

- PMLiVE

Cubist posts positive phase III antibiotic data

CXA-201 on track for 2014 filings

- PMLiVE

FDA backs a brace of allergy immunotherapies

Merck & Co and Stallergenes win drug approvals in US

- PMLiVE

Digital recruitment for clinical trials

As more patients go online for health, digital channels are showing ever-greater promise

- PMLiVE

FDA backs new formulation of Noxafil

Merck wins US approval for delayed-release version of anti-infective

- PMLiVE

AZ strikes antibiotic deal with Singapore research unit

Deal with A*STAR to tackle antimicrobial resistance

- PMLiVE

Merck stakes a claim to all-oral hepatitis C market

Positive data for interferon-free regimen

Roche - Basel

Roche signs €400m superbug deal

Buys rights to investigational antibiotic from Polyphor

- PMLiVE

Merck’s vintafolide shows its worth in ovarian cancer

Phase II data shows improvement on current oncology treatments

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links